OptimizeRx Corp. (OPRX)
NASDAQ • Healthcare
Last close at October 26, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, OptimizeRx Corp. currently loses $3.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 9 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
OptimizeRx topped consensus on both the top and bottom line in the second fiscal quarter of 2026, based on preliminary results reported August 12, 2026, with adjusted EPS of $0.16 topping the $0.11 estimate (+44%) and revenue of $20.5 million topping the $20.2 million estimate (+1.5%). Revenue fell 29.8% year over year to about $20.5 million (down from roughly $29.2 million a year ago), reflecting the quarter’s performance in its digital health messaging and workflow tools delivered through electronic health records. Gross profit came in around $15.7 million, with gross margin at about 77%. Adjusted EPS declined 33.3% year over year to $0.16 (down from $0.24 a year ago), while operating cash flow was about $8.6 million. For the next period, consensus calls for EPS of $0.19 on revenue of $21.6 million.
Next report — what to expect
OptimizeRx Corp. (OPRX) reports earnings on November 5, 2026. Wall Street is looking for EPS of $0.18 on revenue of $21.2 million. For trailing context, revenue fell -29.8% year over year last quarter. OptimizeRx has beaten EPS in 8 of its 8 most recent quarters, making consistency a key watchpoint.
About OptimizeRx Corp.
OptimizeRx Corp. trades on NASDAQ under the ticker OPRX and operates in healthcare information services, supplying digital communications tools that connect drug makers and care teams inside clinical software. The company generated $109.4 million in FY2025 revenue through messaging and workflow products delivered through electronic health records.
Today's Snapshot
The session opened with OPRX slightly higher at 9.11, while its sector was flat. OptimizeRx partnered with PulsePoint, a healthcare advertising platform, to expand access to its healthcare-professional media. OPRX reports earnings on 5 November.
Trading Volume
Below 10d avg (118.8K)
24.5K
vs S&P 500 Today
Outperforming Market
+0.81%
Updated: October 27, 2026 at 14:38 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$7.78 - $8.89Buy
- RSI (14)60.69Neutral
- Stochastic %K (14, 3, 3)66.44Neutral
- MACD Level (12, 26)0.32Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.